
Latest Local Technology Business News
- Blog: With Komen and SOPA, the web has finally grown up
- Rep. Markey bill would block medical devices linked to recalls
- PerkinElmer picks Atlas Venture's Barrett for board seat
- FDA removes hold on Idenix hep C drug target
- Fraud charges dropped on Stryker ex-president Philip
- PC Connection names Driscoll as new CFO
- Report: Cleantech VC dollars down in 2011 nationally
- LeveragePoint leverages backers for $713K more
- Polatis picks up $2.7M in new funding
- Nuclea adds $3.4M to funding round
- Boston Scientific's new stent gets first patient implant
- AstraZeneca layoffs may hit Mass. R&D operation
- T2 Biosystems wins broad patent for NMR-based diagnostics
- Merrimack Pharma reported to delay IPO
- Wing Power Energy's wind turbines fueled by funding
- Startup MyCare gets $1M in seed funding
- MIT makes solar panels from plants
- Zipcar buys majority stake in Spain’s Avancar
- PurposeEnergy pulls a $650K funding draft
- Energy Leaders Breakfast Club: Energy Leaders Breakfast Club: Green Communities Act, energy costs, and volatility
- Parexel enters deal with Korean medical center
- Closing the Deal: Self assessment for driving revenue growth
- Illume's Ross to help straighten out new parent firm
- Sanofi hits Genzyme with layoffs
- SeaChange cuts staff to save company $5M
- CasePick relaunches as Symbotic
- Foundation Medicine gets OK for sequencing lab
- Generex gets $2M investment boost
- Stemgent adds $6.3M to coffers to grow portfolio
- Dana-Farber lands $10M grant for cancer imaging research
- Enterasys leaving Andover, moving back to NH
- AB SCIEX, Thermo Fisher aim for orange juice safety
- Startup Watch: Five you should follow
- FDA approves Vertex cystic fibrosis drug
- Guest Column: Even startups need severance agreements
- iRobot takes $6M stake of InTouch Health
- Silverlink socks away $2M in new funding round
- Navilyst Medical to be bought for $372M by AngioDynamics
- Raytheon wins $10M contract for railgun systems
- Illume being bought by competitor Options Media
- Stem cells may shed light on hepatitis, MIT researchers find
- MIT: Defective enzymes may spell higher cancer risk
- Covidien device joins stroke treatment trial
- Curis gets $10M payment as FDA approves cancer drug
- Blog: Facebook data can – and should – change Congress
- FDA OKs Cynosure cellulite reduction device
- Molecular Insight moves pre-trial compound to manufacturing
- Fledgling Holyoke computer center gives $600,000 in grants
- Seed-stage investor Experiment Fund launches in Cambridge
- RatePoint closing after quiet Constant Contact partial buy
- Startup Co3 Systems lands Series A round
- ConforMIS grabs $89 Million in Series E financing
Friday, February 3, 2012
Thursday, February 2, 2012
Wednesday, February 1, 2012
Tuesday, January 31, 2012
Monday, January 30, 2012

